Hims & Hers Health plummeted to $26.92 per share this afternoon, but it remains 8.1% above its mean target price of $24.9. There may still be room for more downwards movement — even after today's -5.5% drop. Analysts are giving the Mid-Cap Medical and Nursing Services stock on average rating of hold, with target prices ranging from $18.0 to $38.0 per share.
The stock has an unusually large proportion of its shares sold short at 22.2%, and a short ratio of 1.73. Since 11.44% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests. Finally, we also note that an average number of institutional investors are invested in the stock, with 65.3% of Hims & Hers Health's shares being owned by this investor type.
Institutions Invested in Hims & Hers Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-09-30 | Vanguard Group Inc | 9% | 18,236,394 | $490,923,727 |
| 2024-09-30 | Blackrock Inc. | 7% | 15,418,505 | $415,066,155 |
| 2024-09-30 | Renaissance Technologies, LLC | 3% | 5,388,850 | $145,067,842 |
| 2024-09-30 | State Street Corporation | 2% | 4,626,543 | $124,546,537 |
| 2024-09-30 | Institutional Venture Management XVI, LLC | 2% | 4,347,570 | $117,036,584 |
| 2024-09-30 | Geode Capital Management, LLC | 2% | 4,289,549 | $115,474,659 |
| 2024-09-30 | Wellington Management Group, LLP | 2% | 3,444,414 | $92,723,625 |
| 2024-09-30 | Nuveen Asset Management, LLC | 2% | 3,418,485 | $92,025,616 |
| 2024-09-30 | Dimensional Fund Advisors LP | 1% | 2,902,234 | $78,128,139 |
| 2024-09-30 | Institutional Venture Management XV, LLC | 1% | 2,597,558 | $69,926,261 |
Besides an analyst consensus of little upside potential, other market factors point to there being mixed market sentiment on Hims & Hers Health.
